Moderna, Inc. ( MRNA) - Stock Earnings
MRNA Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 5, 2026, midnight | — / — | — | — / — | — |
MRNA Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -826.0 million USD | 678.0 million USD |
| 2026Q1 | -1.3 billion USD | 389.0 million USD |
| 2026Q2 | -782.0 million USD | 145.0 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
MRNA Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -4.7 billion USD | 6.8 billion USD |
| 2024 | -3.6 billion USD | 3.2 billion USD |
| 2025 | -2.8 billion USD | 1.9 billion USD |
| 2026 Est. | — | — |
MRNA
Price: $227.82
Earnings Per Share: -7.98 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 3.3 million
Market Capitalization: 75.4 billion